knowledge -WSS

knowledge

author：fashion 2025-09-28 23:47:51 - browse：942

Smartphone & medicine illustration — Alex Hogan/STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system.

In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022. The data, which take into account health care utilization before and after people used the apps, have been presented to policymakers considering how to cover novel digital health products and shown to lawmakers considering federal legislation that would require Medicare coverage for prescription apps.

Pear, which filed for bankruptcy earlier this year, was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Pear’s reSET was the first such app cleared by the FDA in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： It's time to retire 'poor historian' from clinicians' vocabularies

focus

hotspot

WSS

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Group opposing PBM reform sets lobbying record

Glen Campbell's doctor discusses his public struggle with Alzheimer's

AI can’t replace a physician’s gut feeling

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Venture capitalist Bob Kocher on the state of digital health

entertainment

knowledge

focus

Psychedelics group wrestles with new pharma identity

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Dobbs anniversary: the lost opportunity of abortion as health care

Readers respond to H5N1 and livestock movements, and more

ChatGPT in medicine: STAT answers readers' burning questions

Helping hospitals and community health centers plan for resilience

How to save PrEP access — and even expand it

With measles on the rise, a personal story of a devastating disease

Medicare proposal to cover medical devices draws a mixed reaction

When prostate cancer spreads, where it goes matters

explore

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

NVIDIA and Google execs on the future of AI and drug discovery

Addiction experts warn against a second 'war on drugs'

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

A public scorecard can help hold safety

focus

hotspot

hotspot

leisure time